Glutathione.

Cysteine is the rate-limiting amino acid for glutathione synthesis, and NAC delivers cysteine in a stable form the cell can use. Pairing them supplies both the finished tripeptide and the raw material the body uses to make its own.

Vitamin C and glutathione sit on the same antioxidant recycling loop, where glutathione regenerates oxidized vitamin C and adequate vitamin C spares glutathione from being consumed. Each one keeps the other in its reduced, working form.

Glutathione peroxidase is a selenoenzyme, so it needs a selenocysteine residue built from dietary selenium to act on glutathione at all. Without enough selenium the glutathione pool cannot be used efficiently for peroxide handling.

Dihydrolipoic acid, the reduced form of alpha lipoic acid, can reduce oxidized glutathione back to its active form. That keeps a larger share of the glutathione pool in the reduced state that does the work.

Glutathione is the tripeptide of glutamate, cysteine and glycine, so glycine is one of the three residues the ligase has to join. Glycine availability becomes limiting for synthesis in older adults even when cysteine is plentiful.

Cysteine supply sets the pace of glutathione synthesis, because glutamate cysteine ligase runs below saturation at normal intracellular cysteine. Feeding cysteine raises the substrate for that first committed step.

Glutathione reductase is a flavoprotein carrying FAD, made from riboflavin, and it is the enzyme that returns oxidised glutathione to its reduced form. Without riboflavin the recycling arm slows no matter how much total glutathione is present.

Glutathione reductase spends NADPH to reduce each molecule of oxidised glutathione, and the NADP pool is built from niacin. Niacin status sits one step behind the whole recycling cycle.

Cystathionine beta-synthase and cystathionine gamma-lyase both need pyridoxal phosphate to route homocysteine into cysteine. That route supplies much of the cysteine used for glutathione.

Sulforaphane releases Nrf2, which raises transcription of glutamate cysteine ligase and glutathione synthetase, the two enzymes that assemble the tripeptide. It raises the machinery while precursors supply the parts.

Broccoli sprout extract carries glucoraphanin, converted by myrosinase or gut bacteria to sulforaphane, which upregulates the glutathione synthesis enzymes. It is the whole-food route to the same transcriptional step.

Tocopherol stops lipid chain reactions in membranes and is regenerated by ascorbate, which is itself regenerated at the expense of glutathione. Glutathione sits at the end of the chain that keeps vitamin E working.

Silymarin is used to support the liver's own glutathione content, and the liver is where most whole-body glutathione is made and exported. Support at the site of synthesis complements substrate given by mouth.

Betaine hands a methyl group to homocysteine through betaine homocysteine methyltransferase, which shapes how much homocysteine stays available for the transsulfuration route to cysteine. It is an upstream lever on cysteine supply rather than a direct precursor.

S-acetyl glutathione is the same tripeptide with an acetyl group on the cysteine thiol, added to survive the gut and be cleaved inside cells. A formula carrying both is stacking one molecule in two delivery forms.

Sulfite oxidase is a molybdenum enzyme that finishes the breakdown of cysteine-derived sulfite to sulfate. Pushing more sulfur amino acid into the system leans harder on that molybdenum-dependent step.

Cysteine availability sets the pace of glutathione synthesis in most tissues, and whey protein is unusually rich in cystine-containing fractions that survive digestion. Pairing the two supplies substrate rather than adding a second antioxidant. A systematic review of milk protein supplementation reports changes in oxidative stress markers alongside lipid and liver enzyme measures, which are markers rather than clinical outcomes.

Methionine passes through S-adenosylmethionine and homocysteine into cystathionine, and cystathionine gamma-lyase releases the cysteine used to build glutathione. That route is settled biochemistry and does not depend on a combination trial. It matters most when dietary sulfur amino acid intake is low.

Glutamate cysteine ligase joins glutamate to cysteine, and glutamine is the main circulating carrier that regenerates intracellular glutamate. Gut enterocytes in particular draw on glutamine for both fuel and glutathione building blocks. The relationship is a substrate one, not an additive antioxidant effect.

S-adenosylmethionine sits directly upstream of homocysteine and allosterically pushes cystathionine beta-synthase, the committed step toward cysteine. More flux down that branch means more raw material for glutathione. The connection is mechanistic and is described in standard one-carbon metabolism references.

Cystathionine beta-synthase needs serine as its second substrate, so serine supply gates the conversion of homocysteine into cysteine. Serine also feeds the folate cycle that keeps the methionine cycle turning. Both roles sit upstream of glutathione rather than beside it.

Methylcobalamin drives methionine synthase, which decides whether homocysteine is remethylated or handed to the transsulfuration branch that ends in cysteine and glutathione. Low B12 status backs the cycle up. This is a cofactor relationship described in every biochemistry text.

5-methyltetrahydrofolate hands its methyl group to homocysteine through methionine synthase, keeping the cycle that feeds transsulfuration turning. Folate status therefore sits two steps upstream of cysteine availability. The pathway is established, and no combination trial is needed to state it.

Both enzymes that build glutathione, glutamate cysteine ligase and glutathione synthetase, hydrolyse ATP and act on the magnesium-ATP complex. Magnesium is a permissive cofactor rather than an additive antioxidant. The requirement is standard enzymology.

Cysteine can be oxidised toward taurine through cysteine dioxygenase or drawn into glutathione synthesis, and the two routes draw on one pool. Supplying taurine directly can spare cysteine for glutathione, while conditions that push taurine synthesis pull the other way. Worth flagging as a shared-substrate relationship rather than a simple pairing.

Free copper cycles between its two oxidation states and oxidises thiols, so unbound copper drains reduced glutathione while glutathione in turn buffers copper by binding it. In practice glutathione acts as a copper chaperone and a sink at the same time. The interaction is chemistry, not a claim about any outcome.

Loosely bound iron generates hydroxyl radicals from peroxide, and the resulting oxidative load is met by reduced glutathione, lowering the reduced to oxidised ratio. Glutathione also participates in intracellular iron trafficking as a low molecular weight ligand. The two are chemically entangled rather than simply additive.

Zinc induces metallothionein, a cysteine-rich protein that buffers reactive metals and electrophiles in parallel with glutathione. Zinc is redox-inert itself, so it adds capacity without adding redox cycling. The overlap is mechanistic and the human data on the pairing is thin.

Quercetin oxidation products are electrophilic quinones that glutathione conjugates and clears, and quercetin also shows up alongside glutathione in Nrf2-driven phase II induction. The relationship runs both ways: glutathione handles quercetin metabolites, and quercetin can raise the enzymes that make glutathione. Most of this sits in cell and animal work.

Curcumin is a Michael acceptor that reacts with cysteine thiols and, in doing so, induces the Nrf2 programme that raises glutathione synthesis enzymes. A systematic review of curcumin in adults with high blood sugar reports movement in inflammation and oxidative stress markers, which are markers rather than clinical outcomes. Curcumin is also cleared in part as a glutathione conjugate.

Resveratrol raises glutamate cysteine ligase expression in cell and animal models through the Nrf2 pathway. That is an induction effect on the machinery rather than a direct radical-scavenging partnership. Human data on the combination is limited.

Melatonin crosses membranes readily and reaches mitochondria, where glutathione concentrations are maintained by a separate transport pool. The two are among the most frequently co-studied antioxidants in the oxidative stress literature. Most of that co-study is preclinical.

Astaxanthin spans the membrane bilayer and quenches lipid-phase radicals, a compartment reduced glutathione cannot reach directly. Glutathione instead maintains the aqueous thiol pool and regenerates other reductants. Pairing them covers two different physical spaces rather than doubling one effect.

Ubiquinol is the membrane-resident reductant that regenerates tocopheroxyl radicals, while glutathione supports the aqueous side of the same network. The recycling chain from glutathione through ascorbate to tocopherol is textbook, and coenzyme Q10 feeds the lipid end of it. The pairing is mechanistic rather than trial-backed.

EGCG auto-oxidises to quinones that glutathione conjugates through glutathione S-transferases, which is part of how catechins are handled. EGCG also induces phase II enzymes in preclinical models. High catechin exposure can consume thiol capacity, so the direction depends on dose.

An umbrella review of meta-analyses of vitamin D supplementation reports movement in inflammatory biomarkers, a marker-level finding and not an outcome. Glutathione-linked redox markers appear among the measures tracked in that literature. The link is co-reporting, not a demonstrated combination effect.